Journal article

A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype

MV Evans-Galea, LA Corben, J Hasell, CA Galea, MC Fahey, D Du Sart, MB Delatycki

Neurogenetics | SPRINGER | Published : 2011

Abstract

Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disease most commonly caused by a GAA trinucleotide repeat expansion in the first intron of FXN, which reduces expression of the mitochondrial protein frataxin. Approximately 98% of individuals with FRDA are homozygous for GAA expansions, with the remaining 2% compound heterozygotes for a GAA expansion and a point mutation within FXN. Two siblings with early onset of symptoms experienced rapid loss of ambulation by 8 and 10 years. Diagnostic testing for FRDA demonstrated one GAA repeat expansion of 1010 repeats and one non-expanded allele. Sequencing all five exons of FXN identified a novel deletion-insertion mutation in ex..

View full abstract

University of Melbourne Researchers

Grants

Funding Acknowledgements

The authors would like to sincerely thank the participating family as well as Gabrielle Wilson and Paul Lockhart for their assistance. This study was supported by funding from the Friedreich Ataxia Research Alliance, USA, the Friedreich Ataxia Research Association, Australasia, the Australian Rotary Health Research Fund, the North Brighton Rotary Club, the Collier Charitable Fund of Australia and the Victorian Government Operational Infrastructure Support Program. MBD is a National Health and Medical Research Council of Australia Practitioner Fellow.